At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,635 enrolled
Drug / intervention
This is Non-interventional studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Post Marketing Observational Study to Evaluate the Safety of Pletaal® SR Capsule
In Brief
An observational study evaluating This is Non-interventional study for Ischemic Symptoms and Cerebral Infarction. Completed, enrolled 3,635 participants across 4 sites.
Detailed Summary
This is a Post Marketing Observational Study of cilostazol (Pletaal® SR capsule). As this study is observational in nature to collect the safety data after administrating the Pletaal SR capsule, from baseline to 16 weeks.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Symptoms, Cerebral Infarction
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2013
First PostedFeb 2013
Primary CompletionDec 2014
TodayJul 2026
First PostedFeb 4, 2013
Enrollment StartJan 1, 2013
Primary CompletionDec 31, 2014
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 13.4 years ago
Interventions
This is Non-interventional studyother